n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with isoproterenol in 1 studies
Studies (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Trials (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Recent Studies (post-2010) (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Studies (isoproterenol) | Trials (isoproterenol) | Recent Studies (post-2010) (isoproterenol) |
---|---|---|---|---|---|
79 | 1 | 16 | 30,780 | 803 | 2,640 |
Protein | Taxonomy | n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine (IC50) | isoproterenol (IC50) |
---|---|---|---|
Beta-2 adrenergic receptor | Homo sapiens (human) | 0.246 | |
Beta-1 adrenergic receptor | Homo sapiens (human) | 0.333 | |
Beta-2 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2125 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 1.77 | |
Beta-1 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2125 | |
Beta-3 adrenergic receptor | Rattus norvegicus (Norway rat) | 0.2125 | |
Beta-2 adrenergic receptor | Canis lupus familiaris (dog) | 0.6667 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arthur, GD; Belcastro, AN | 1 |
1 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and isoproterenol
Article | Year |
---|---|
A calcium stimulated cysteine protease involved in isoproterenol induced cardiac hypertrophy.
Topics: Adrenergic beta-Agonists; Animals; Calcium; Calpain; Cardiomegaly; Cyclic AMP; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Enzyme Activation; Isoproterenol; Leucine; Male; Rats; Rats, Wistar; RNA; Ventricular Function, Left | 1997 |